These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19479832)

  • 1. Time course and nature of brain atrophy in the MRL mouse model of central nervous system lupus.
    Sled JG; Spring S; van Eede M; Lerch JP; Ullal S; Sakic B
    Arthritis Rheum; 2009 Jun; 60(6):1764-74. PubMed ID: 19479832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin aggravates CNS pathology in experimental systemic lupus erythematosus.
    Foxley S; Zamora M; Hack B; Alexander RR; Roman B; Quigg RJ; Alexander JJ
    Brain Res; 2013 Apr; 1504():85-96. PubMed ID: 23410788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of functional alternative complement pathway alleviates lupus cerebritis.
    Alexander JJ; Jacob A; Vezina P; Sekine H; Gilkeson GS; Quigg RJ
    Eur J Immunol; 2007 Jun; 37(6):1691-701. PubMed ID: 17523212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression prevents neuronal atrophy in lupus-prone mice: evidence for brain damage induced by autoimmune disease?
    Sakic B; Kolb B; Whishaw IQ; Gorny G; Szechtman H; Denburg JA
    J Neuroimmunol; 2000 Nov; 111(1-2):93-101. PubMed ID: 11063826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive knockout of interleukin-6 ameliorates memory deficits and entorhinal astrocytosis in the MRL/lpr mouse model of neuropsychiatric lupus.
    Reynolds J; Huang M; Li Y; Meineck M; Moeckel T; Weinmann-Menke J; Mohan C; Schwarting A; Putterman C
    J Neuroinflammation; 2024 Apr; 21(1):89. PubMed ID: 38600510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice.
    Anderson KK; Ballok DA; Prasad N; Szechtman H; Sakic B
    Behav Brain Res; 2006 Jan; 166(1):32-8. PubMed ID: 16183144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal damage in mouse and human forms of systemic autoimmune disease.
    Ballok DA; Woulfe J; Sur M; Cyr M; Sakic B
    Hippocampus; 2004; 14(5):649-61. PubMed ID: 15301441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis.
    Alexander JJ; Bao L; Jacob A; Kraus DM; Holers VM; Quigg RJ
    Biochim Biophys Acta; 2003 Nov; 1639(3):169-76. PubMed ID: 14636948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodegeneration in autoimmune MRL-lpr mice as revealed by Fluoro Jade B staining.
    Ballok DA; Millward JM; Sakic B
    Brain Res; 2003 Feb; 964(2):200-10. PubMed ID: 12576180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE).
    Li Y; Eskelund AR; Zhou H; Budac DP; Sánchez C; Gulinello M
    Int J Mol Sci; 2015 Jul; 16(7):15150-71. PubMed ID: 26151848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotoxic properties of cerebrospinal fluid from behaviorally impaired autoimmune mice.
    Maric D; Millward JM; Ballok DA; Szechtman H; Denburg JA; Barker JL; Sakic B
    Brain Res; 2001 Nov; 920(1-2):183-93. PubMed ID: 11716824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune-induced damage of the midbrain dopaminergic system in lupus-prone mice.
    Ballok DA; Earls AM; Krasnik C; Hoffman SA; Sakic B
    J Neuroimmunol; 2004 Jul; 152(1-2):83-97. PubMed ID: 15223241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive atrophy of pyramidal neuron dendrites in autoimmune MRL-lpr mice.
    Sakić B; Szechtman H; Denburg JA; Gorny G; Kolb B; Whishaw IQ
    J Neuroimmunol; 1998 Jul; 87(1-2):162-70. PubMed ID: 9670858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered olfactory function in the MRL model of CNS lupus.
    Kapadia M; Stanojcic M; Earls AM; Pulapaka S; Lee J; Sakic B
    Behav Brain Res; 2012 Oct; 234(2):303-11. PubMed ID: 22796602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of brain metabolites by gas chromatography-mass spectrometry reveals the risk-benefit concerns of prednisone in MRL/lpr lupus mice.
    Zhou J; Lu F; Li S; Xie M; Lu H; Xie Z; Wu D; Wang S; Wen C; Xu ZH
    Inflammopharmacology; 2020 Apr; 28(2):425-435. PubMed ID: 31786803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The T Cell Receptor Repertoire in Neuropsychiatric Systemic Lupus Erythematosus.
    Moore E; Huang MW; Jain S; Chalmers SA; Macian F; Putterman C
    Front Immunol; 2020; 11():1476. PubMed ID: 32765512
    [No Abstract]   [Full Text] [Related]  

  • 17. CXCL13 Neutralization Attenuates Neuropsychiatric Manifestations in Lupus-Prone Mice.
    Huang MW; Stock AD; Putterman C
    Front Immunol; 2021; 12():763065. PubMed ID: 34868008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.
    Stock AD; Wen J; Doerner J; Herlitz LC; Gulinello M; Putterman C
    J Neuroinflammation; 2015 Nov; 12():205. PubMed ID: 26546449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating brain-reactive autoantibodies and behavioral deficits in the MRL model of CNS lupus.
    Williams S; Sakic B; Hoffman SA
    J Neuroimmunol; 2010 Jan; 218(1-2):73-82. PubMed ID: 19919882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.
    Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C
    J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.